concept

ADUCANUMAB

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ADUCANUMAB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

97Connections

0Hypotheses

0Analyses

35Outgoing

21Incoming

No summary available yet. View on Wiki →

💡 Concept Info

Name	ADUCANUMAB
Summary	Comprehensive information on aducanumab (Aduhelm), the anti-amyloid monoclonal antibody for Alzheimer's disease, including clinical trials, FDA approval history, and mechanism of action
Key Genes/Proteins	HK2, STING, AMYLOID
Related Diseases	COGNITIVE DECLINE, ALZHEIMER, ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, CSF

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Pathway Diagram

graph TD
    ADUCANUMAB["ADUCANUMAB"]
    ADUCANUMAB -->|"targets"| AMYLOID_BETA["AMYLOID-BETA"]
    ADUCANUMAB -->|"treats"| Alzheimer_S_Disease["Alzheimer'S Disease"]
    ADUCANUMAB -->|"treats"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
    ADUCANUMAB -->|"target for"| LECANEMAB["LECANEMAB"]
    ADUCANUMAB -->|"inhibits"| Amyloid["Amyloid"]
    ADUCANUMAB -->|"regulates"| terminally_inflammatory_microg["terminally inflammatory microglia"]

Outgoing (75)

Target	Relation	Type	Str
LECANEMAB	therapeutic_target	drug	0.80
LECANEMAB	targets	drug	0.65
STING	inhibits	gene	0.65
ALZHEIMER	targets	disease	0.65
ALZHEIMER'S DISEASE	targets	disease	0.65
AMYLOID	synergizes_with	protein	0.60
DONANEMAB	therapeutic_target	drug	0.50
NEURON	associated_with	cell_type	0.50
APP	associated_with	gene	0.50
TAU	associated_with	protein	0.50
AGING	associated_with	phenotype	0.50
APOE	associated_with	gene	0.50
HK2	associated_with	gene	0.50
TREM2	associated_with	gene	0.50
MICROGLIA	associated_with	cell_type	0.50
PARKINSON	associated_with	disease	0.50
BACE1	associated_with	gene	0.50
BDNF	associated_with	gene	0.50
NGF	associated_with	gene	0.50
ASTROCYTE	associated_with	cell_type	0.50
CSF	associated_with	phenotype	0.50
LECANEMAB	associated_with	drug	0.45
DONANEMAB	associated_with	drug	0.45
ALZHEIMER	associated_with	disease	0.45
AMYLOID	associated_with	protein	0.45
ALZHEIMER'S DISEASE	associated_with	disease	0.45
MAG	associated_with	gene	0.45
MITOCHONDRIA	associated_with	phenotype	0.45
FUS	associated_with	gene	0.45
DEMENTIA	associated_with	disease	0.45
CRENEZUMAB	associated_with	drug	0.45
ALZHEIMER'S DISEASE	regulates	disease	0.35
FUS	activates	gene	0.35
ALZHEIMER'S DISEASE	inhibits	disease	0.35
ad_clinical_trial_failures:aducanumab	data_in	dataset_row	0.00

Incoming (22)

Source	Relation	Type	Str
HK2	inhibits	gene	0.70
COGNITIVE DECLINE	interacts_with	phenotype	0.70
PARKINSON'S DISEASE	targets	disease	0.65
DONANEMAB	treats	drug	0.65
DONANEMAB	causes	drug	0.65
CSF	interacts_with	phenotype	0.60
CSF	synergizes_with	phenotype	0.60
MITOCHONDRIAL DYSFUNCTION	associated_with	phenotype	0.50
PROTEIN AGGREGATION	associated_with	phenotype	0.50
PROTEOSTASIS	associated_with	phenotype	0.50
NEUROINFLAMMATION	associated_with	phenotype	0.50
COGNITIVE DECLINE	associated_with	phenotype	0.50
PARKINSON'S DISEASE	associated_with	disease	0.50
NEURODEGENERATION	associated_with	phenotype	0.50
ALZHEIMER'S DISEASE	associated_with	disease	0.45
AMYLOID PLAQUES	associated_with	phenotype	0.45
AMYLOID-BETA	associated_with	protein	0.45
GANTENERUMAB	associated_with	drug	0.45
SOLANEZUMAB	associated_with	drug	0.45
MULTIPLE SCLEROSIS	associated_with	disease	0.45
ad_clinical_trial_failures:aducanumab	data_in	dataset_row	0.00

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

ADUCANUMAB

Understanding Entity Pages

Wiki Pages (21)

Aduhelm

nhp-validation-animal-model

Therapeutics

Alzheimer's Disease

dendritic-spines

Blood-Brain Barrier Biology and Crossing Strategies

PMN310 Anti-Amyloid for AD (NCT06750432)

Clinical Trials Dashboard

Amyloid Cascade Pathway

Protein Aggregation Comparison in Neurodegeneration

Amyloid-Beta Aggregation and Plaque Formation

Notch Signaling Pathway in Neurodegeneration

Brain Network Connectivity in PSP

AD Biomarker-to-Mechanism Mapping

AD Cure Roadmap — Integrated Timeline

Amyloid Precursor Protein (APP)

ad-prevention-vs-treatment

Johnson & Johnson

Ion Channel Dysfunction in Alzheimer's Disease